TY  - JOUR
AU  - Martinez-Cuadron, David
AU  - Megias-Vericat, Juan E
AU  - Serrano, Josefina
AU  - Martinez-Sanchez, Pilar
AU  - Rodriguez-Arboli, Eduardo
AU  - Gil, Cristina
AU  - Aguiar, Eliana
AU  - Bergua, Juan
AU  - Lopez-Lorenzo, Jose L
AU  - Bernal, Teresa
AU  - Espadana, Ana
AU  - Colorado, Mercedes
AU  - Rodriguez-Medina, Carlos
AU  - Lopez-Pavia, Maria
AU  - Tormo, Mar
AU  - Algarra, Lorenzo
AU  - Amigo, Maria-Luz
AU  - Sayas, Maria J
AU  - Labrador, Jorge
AU  - Rodriguez-Gutierrez, Juan I
AU  - Benavente, Celina
AU  - Costilla-Barriga, Lissette
AU  - Garcia-Boyero, Raimundo
AU  - Lavilla-Rubira, Esperanza
AU  - Vives, Susana
AU  - Herrera, Pilar
AU  - Garcia-Belmonte, Daniel
AU  - Herraez, Maria Mar
AU  - Vasconcelos Esteves, Graça
AU  - Gomez-Roncero, Maria I
AU  - Cabello, Ana
AU  - Bautista, Guiomar
AU  - Balerdi, Amaia
AU  - Mariz, Jose
AU  - Boluda, Blanca
AU  - Sanz, Miguel A
AU  - Montesinos, Pau
PY  - 2021
DO  - 10.1182/bloodadvances.2021005335
UR  - http://hdl.handle.net/10668/20247
T2  - Blood advances
AB  - Secondary acute myeloid leukemia (sAML) comprises a heterogeneous group of patients and is associated with poor overall survival (OS). We analyze the characteristics, treatment patterns, and outcomes of adult patients with sAML in the Programa Español...
LA  - en
PB  - American Society of Hematology
KW  - Neoplasms, second primary
KW  - Registries
KW  - Remission induction
KW  - Adult
KW  - Aged
KW  - Humans
KW  - Leukemia, myeloid, acute
KW  - Myelodysplastic syndromes
TI  - Treatment patterns and outcomes of 2310 patients with secondary acute myeloid leukemia: a PETHEMA registry study.
TY  - research article
VL  - 6
ER  -